Our research presentations
This section lists presentations of our research results for medical professionals and researchers. To see presentations tailor-made for individuals with 22q11.2DS, their families and caregivers, or the general public, please go to our presentations page.
Research presentations in 2016
Two-Day Workshop on 22q11.2 Deletion Syndrome
Hong Kong, China
December 1st to 2nd, 2016
On the first day, Dr. Bassett gave a lecture on brain and behaviour and adult complications as part of the programme on the clinical aspects of 22q11.2DS. On the second day, she talked about 22q11.2DS as a model for studying schizophrenia. She also played an important role in the discussions on how to set up a 22q11.2DS multidisciplinary clinic.
Schizophrenia Society of Canada National Conference
Halifax, Nova Scotia, Canada
October 27th, 2016
Dr. Bassett presented as the keynote speaker in this conference, delivering a talk about the clinical application of genetics for schizophrenia. She detailed clinical genetic testing and what the current standards of care are, and gave practical examples of how this relates to individuals with 22q11.2DS.
American Society of Human Genetics 2016 Meeting
Vancouver, British Columbia, Canada
October 20th, 2016
Dr. Bassett presented a study that showed significantly higher prevalence of obesity in individuals with 22q11.2DS compared to the Canadian norm. Psychotropic medication and age were associated with higher obesity levels. (Program number: 3308T)
The 10th Biennial International 22q11.2 Conference
July 20th to 22nd, 2016
At this international 22q meeting, Dr. Bassett presented on rare copy number variations in 22q11.2DS with and without schizophrenia. Dr. Boot presented on movement abnormalities in 22q11.2DS. As well, Clinic social worker Lisa Palmer presented initial findings from her study on psychosexual knowledge in people with 22q11.2DS.
Society of Biological Psychiatry Annual Scientific Convention
Atlanta, Georgia, USA
May 12th to 14th, 2016
At this annual meeting, Dr. Bassett presented along with Dr. Erik Boot and other 22q11.2DS researchers on 22q11.2DS as a valuable model for understanding schizophrenia, parkinson’s disease and other neuropsychiatric disorders. The various presenters demonstrated how early changes to the brain can be identified in individuals with 22q11.2DS, which can help elucidate pre-diagnostic signs of disease and therapeutic targets.
Research Presentations in 2015
Society of Biological Psychiatry 70th Annual Scientific Meeting
Toronto, Ontario, Canada
May 16th, 2015
Dr. Bassett presented at this annual meeting the results of a study which investigating the link between 22q11.2 deletions and risk for schizophrenia during pregnancy. Nancy Butcher also presented her results on use of clozapine in schizophrenia for individuals with 22q11.2DS.
72nd Annual Meeting & Pre-Conference Symposia of the American Cleft Palate-Craniofacial Association
Palm Springs, California, USA
April 20, 2015
Alongside our collaborator Donna McDonald-McGinn, Dr. Bassett presented the results of the practice guidelines for managing patients with 22q11.2DS and how this relates to the assessment and treatment of palatal abnormalities. Here is the abstract.
Research Presentations in 2014
University of Hong Kong Grand Rounds
Hong Kong, China
November 6th, 2014
At the University of Hong Kong Grand Rounds, Dr. Bassett presented the latest research on 22q11.2DS and the genetics of congenital cardiac disease.
22q11.2 Deletion Syndrome International Meeting
June 19, 2014
At this biennial international 22q11.2DS meeting, Dr. Bassett presented on antipsychotic treatment with clozapine in adults with 22q, and how to use a model of personalized care with patients.